Evidence map›Paper›PMID 38840208›Full record

ArticleJournal of neuroengineering and rehabilitation2024

Evaluation of walking activity and gait to identify physical and mental fatigue in neurodegenerative and immune disorders: preliminary insights from the IDEA-FAST feasibility study.

Chloe Hinchliffe, Rana Zia Ur Rehman, Clemence Pinaud, Diogo Branco, Dan Jackson, Teemu Ahmaniemi, Tiago Guerreiro, Meenakshi Chatterjee, Nikolay V Manyakov, Ioannis Pandis and 15 more

Abstract read
In one paragraph

Article in Journal of neuroengineering and rehabilitation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Chloe HinchliffeTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, The Catalyst, 3 Science Square, Room 3.27, Newcastle Upon Tyne, NE4 5TG, UK.
Rana Zia Ur RehmanJanssen Research & Development, High Wycombe, UK.
Clemence PinaudLet It Care, Rennes, France.
Diogo BrancoLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal.
Dan JacksonOpen Lab, School of Computing, Newcastle University, Newcastle Upon Tyne, UK.
Teemu AhmaniemiVTT, Visiokatu 4, 33720, Tampere, Finland.
Tiago GuerreiroLASIGE, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal.
Meenakshi ChatterjeeJanssen Research & Development, Cambridge, USA.
Nikolay V ManyakovJanssen Research & Development, Beerse, Belgium.
Ioannis PandisPfizer, Thessaloniki, Central Macedonia, Greece.
Kristen DaviesTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, The Catalyst, 3 Science Square, Room 3.27, Newcastle Upon Tyne, NE4 5TG, UK.
Victoria MacraeNIHR Newcastle Clinical Research Facility, Newcastle Upon Tyne, UK.
Svenja AufenbergGeorge-Huntington-Institute, Muenster, Germany.
Emma PaulidesDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Hanna HildesheimDepartment of Neurology, University Medical Center Schleswig-Holstein Campus, Kiel, Germany.
Jennifer KudelkaDepartment of Neurology, University Medical Center Schleswig-Holstein Campus, Kiel, Germany.
Kirsten EmmertDepartment of Neurology, University Medical Center Schleswig-Holstein Campus, Kiel, Germany.
Geert Van GassenMedical Affairs, Takeda, Brussels, Belgium.
Lynn RochesterTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, The Catalyst, 3 Science Square, Room 3.27, Newcastle Upon Tyne, NE4 5TG, UK.
C Janneke van der WoudeDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Ralf ReilmannGeorge-Huntington-Institute, Muenster, Germany.
Walter MaetzlerDepartment of Neurology, University Medical Center Schleswig-Holstein Campus, Kiel, Germany.
Wan-Fai NgTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, The Catalyst, 3 Science Square, Room 3.27, Newcastle Upon Tyne, NE4 5TG, UK.
Silvia Del DinTranslational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, The Catalyst, 3 Science Square, Room 3.27, Newcastle Upon Tyne, NE4 5TG, UK. silvia.del-din@ncl.ac.uk.
IDEA-FAST Consortium

Funding

EU Innovative Medicines Initiative 2 Joint Undertaking 853981
6 · The paper itself

Abstract

backgroundMany individuals with neurodegenerative (NDD) and immune-mediated inflammatory disorders (IMID) experience debilitating fatigue. Currently, assessments of fatigue rely on patient reported outcomes (PROs), which are subjective and prone to recall biases. Wearable devices, however, provide objective and reliable estimates of gait, an essential component of health, and may present objective evidence of fatigue. This study explored the relationships between gait characteristics derived from an inertial measurement unit (IMU) and patient-reported fatigue in the IDEA-FAST feasibility study.

methodsParticipants with IMIDs and NDDs (Parkinson's disease (PD), Huntington's disease (HD), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), primary Sjogren's syndrome (PSS), and inflammatory bowel disease (IBD)) wore a lower-back IMU continuously for up to 10 days at home. Concurrently, participants completed PROs (physical fatigue (PF) and mental fatigue (MF)) up to four times a day. Macro (volume, variability, pattern, and acceleration vector magnitude) and micro (pace, rhythm, variability, asymmetry, and postural control) gait characteristics were extracted from the accelerometer data. The associations of these measures with the PROs were evaluated using a generalised linear mixed-effects model (GLMM) and binary classification with machine learning.

resultsData were recorded from 72 participants: PD = 13, HD = 9, RA = 12, SLE = 9, PSS = 14, IBD = 15. For the GLMM, the variability of the non-walking bouts length (in seconds) with PF returned the highest conditional R2, 0.165, and with MF the highest marginal R2, 0.0018. For the machine learning classifiers, the highest accuracy of the current analysis was returned by the micro gait characteristics with an intrasubject cross validation method and MF as 56.90% (precision = 43.9%, recall = 51.4%). Overall, the acceleration vector magnitude, bout length variation, postural control, and gait rhythm were the most interesting characteristics for future analysis.

conclusionsCounterintuitively, the outcomes indicate that there is a weak relationship between typical gait measures and abnormal fatigue. However, factors such as the COVID-19 pandemic may have impacted gait behaviours. Therefore, further investigations with a larger cohort are required to fully understand the relationship between gait and abnormal fatigue.

Indexed as

FatigueGaitImmune System DiseasesMental FatigueNeurodegenerative DiseasesWalkingAccelerometryAdultAgedFeasibility StudiesFemaleGait AnalysisHumansMaleMiddle AgedSelf ReportDigital healthFatigueMachine learningReal-world gaitWalkingWearable devices

Identifiers

PMID38840208
PMCPMC11151484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.